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Abstract 
Background: Tuberculosis (TB) and the HIV epidemics have been well known previously but now these are 
emerging as a combined epidemic to pose new public health challenges. TB is the most common opportunistic 
infection found among HIV positive individuals. Aims & Objective: To find the prevalence of HIV infection among 
the TB patients diagnosed and put on treatment under RNTCP. 2. To assess their treatment outcomes in 
Chandigarh. Material & Methods: The present study was designed as a retrospective cohort study among the 
adult population (>18 years) in Chandigarh from April 2012 - March 2014. All the TB patients registered for 
treatment at the 17 DMCs of Chandigarh, during this period were taken as the study population. The treatment 
outcome among TB-HIV co-infected patients was compared with those having only Tuberculosis. Results: From 1st 
April 2012 - 31st March 2013, a total of 3,551 patients were registered under RNTCP for treatment of tuberculosis. 
Among the total patients put on DOTS (3,551), 63.2% (2,246) were males and 36.7% (1,305) were females.  A total 
of 3,516 TB patients had their blood tested for HIV. Out of these patients, 88 (2.47%) were tested positive for HIV. 
HIV positive status was also found to be significantly associated with occurrence of extra pulmonary tuberculosis 
(X2= 17.42; df 2; p 0.0001). Category – II treatment was found to be slightly more among the HIV positive TB 
patients as compared to the HIV negative patients. From the total sample, 2.19% (78) patients were later 
diagnosed as having drug resistant tuberculosis with only one (01) patient being co-infected with HIV. Out of all 
the TB-HIV co-infected patients, 29.55% were declared cured at the end of the treatment. A total of 63.64% of co-
infected patients had completed their treatment. Death as an outcome was significantly associated with HIV 
positive status (1.14%) as compared to HIV negative patients. Conclusion: Integration of TB-HIV collaborative 
activities at every level will strengthen our battle to control TB and HIV globally. 
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Introduction  
Tuberculosis (TB) and the HIV epidemics have been 
well known previously but now these are emerging 
as a combined epidemic to pose new public health 
challenges.(1) HIV positive patients have a higher 
propensity to acquire secondary tuberculosis 
following a primary infection. 
HIV infection provides a suitable environment for 
promotion of secondary TB infection both in people 
with recently acquired TB infection and with latent 
M. Tuberculosis infection. As per the database for 
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global tuberculosis report 2014, approximately 
120,000 HIV-positive TB cases occurred in India in 
2013.(2) India has the highest TB burden in the world 
and accounts for 23% of the global incidence of TB 
cases.(3) 
Early diagnosis and effective treatment of active TB 
disease in HIV-infected patients is imperative for 
curing TB and reducing its ill effects on progression 
of HIV. High-quality diagnosis and treatment for TB is 
provided nationwide under the Revised National TB 
Control Programme (RNTCP). The standardized 
supervised regimens of RNTCP are equally effective 
in HIV-positive patients.(4) The interaction between 
HIV and TB is bidirectional and synergistic. On one 
hand, HIV infection predisposes to the development 
of active TB, and, on the other, the course of HIV-
related immunodeficiency is worsened by active TB 
infection leading to a high case fatality rate.(5) 
As per NACO India HIV estimations report of 2015(6), 
the prevalence of HIV infection in adult population 
has been estimated to be 0.26% of the population. 
Although country has showed a steady decline in HIV 
prevalence with 0.34% in 2007 to 0.26% in 2015, 
Chandigarh along with Maharashtra, Tripura and 
Tamil Nadu has shown estimated adult HIV 
prevalence greater than the national prevalence 
(0.26%). TB continues to be a public health challenge 
in India and is estimated that 1.9 million new cases 
of TB occur in India annually. 
India has well-structured and functional national 
programs for the control of both HIV and TB; the 
National AIDS Control Program (NACP) and the 
Revised National TB Control Program (RNTCP) 
respectively. TB/HIV collaborative activities had 
started in 2001 and now with development of 
intensified TB/HIV comprehensive package of 
services being offered to all states in the country 
since 2011.(7) 
Also, it is noteworthy that TB is the most common 
opportunistic infection (OI) among HIV positive 
patients and about a third of HIV infected individuals 
worldwide are co-infected with TB infection. To 
achieve optimal results and effectiveness of the 
TB/HIV co-ordination activities, the HIV care 
providers do screen their patients for TB in the initial 
phase of therapy and accordingly establish linkages 




Aims & Objectives 
1. To find the prevalence of HIV infection among 
the TB patients diagnosed and put on treatment 
under RNTCP. 
2. To know the percentage of referral of TB patients 
to the nearest ICTC for HIV counseling and 
testing in Chandigarh.  
3. To compare the outcomes of TB treatment in 
TB/HIV co-infected patients and only TB patients 
registered under the RNTCP within the same 
area. 
Material & Methods 
As per details from Census 2011(9), Chandigarh has 
a population of 10.55 Lakhs. Chandigarh has Punjab, 
Haryana and Himachal Pradesh in its neighborhood. 
Hence there is a continuous influx of migratory 
population in the city.  
The present study was designed as a retrospective 
cohort study among the adult population (>18 years) 
in Chandigarh from April 2012 - March 2014. All the 
TB patients registered for treatment at the 17 DMCs 
of Chandigarh (3,551), during this period were taken 
as the study population. These also included the 
patients who were referred from the ART centre (37) 
for initiation of TB treatment. They were followed up 
till their treatment outcome was known. The 
treatment outcome among TB-HIV co-infected 
patients was compared with those having only 
Tuberculosis. 
Inclusion Criteria:  
 Adults 18 years of age or more. 
 Residents of Chandigarh. 
 Category I or Category II patients as per RNTCP. 
 All HIV positive patients diagnosed for TB and 
referred from ART Centre. 
 All the patients who had started their anti-
tubercular treatment in the year 2012 and 2013 
and their treatment outcome declared in 2013-
14. 
Exclusion Criteria: 
 Patients not residing in Chandigarh. 
 Patients not registered in RNTCP. 
 Patients already undergoing treatment for Drug 
Resistant Tuberculosis. 
 Age <18 years. 
Study Population and Strategy: 
There are a total of 17 DMCs in Chandigarh. In the 
year 2012 and 2013, 3,551 new TB Cases including 
both Pulmonary and Extra pulmonary, were enrolled 
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at the Designated Microscopy Centers (DMC). The 
data of all the eligible patients enrolled during the 
above said period was taken from the DMCs with due 
permission of Director Health Services, Chandigarh.  
The data of these patients was analyzed in terms of: 
socio-demographic details, category of tuberculosis 
as per RNTCP - category I or category II: 
categorization of the patients was done by the 
medical officer in-charge of the DMC, type of 
tuberculosis - pulmonary or extra pulmonary, HIV 
status, treatment outcome as per RNTCP - Cured, 
Treatment complete, Loss to follow up, Treatment 
Failure, change of regimen, Not evaluated or died. 
Diagnosis of Tuberculosis in Chest Symptomatics: 
The diagnosis of tuberculosis was based on the 
RNTCP protocol. TB was suspected in a patient if 
he/she had any of the following four cardinal 
symptoms: Cough more than 2 weeks with/without 
expectoration, Loss of weight, Loss of appetite, 
Evening rise of fever with night sweats, Ziehl-Neilsen 
(ZN) staining of sputum for demonstration of acid-
fast bacilli (AFB) was then performed by experienced 
lab technician as per RNTCP recommendations at the 
DMC. Patient was then categorized accordingly and 
put on treatment by the concerned medical officer 
of the DMC.  
Diagnosis of HIV positive state in Tuberculosis 
patients: All the patients put on Anti-tubercular 
Treatment (ATT) were referred to the nearest 
Integrated Counseling and Testing Center (ICTC) for 
provider initiated counseling and HIV testing. Any 
patient tested and confirmed positive for HIV at the 
ICTC was first put on ATT and then referred to the 
ART center at PGIMER, Chandigarh for receiving ART.  
As per the recent guidelines of WHO, all the TB-HIV 
co-infected patients were put on ART irrespective of 
the CD4 count. All the co-infected patients were also 
given CPT at the ART center. 
Diagnosis of Tuberculosis in HIV positive patients: 
The World Health Organization currently 
recommends (10) that all HIV infected persons 
should be screened for TB, and HIV infected persons 
without active TB disease be evaluated for latent TB 
infection. The WHO recommends TB screening at the 
time that HIV infection is diagnosed, before the 
initiation of antiretroviral therapy and at regular 
intervals during follow up. All the patients diagnosed 
as HIV positive were screened for tuberculosis at the 
ART Center, PGIMER, Chandigarh. Screening was 
done through clinical assessment and radiological 
methods. Any patient reported as tuberculosis 
suspect (pulmonary or extra pulmonary) was then 
referred to the nearest DMC for sputum microscopy 
and further initiation of ATT. 
Treatment Outcome: Treatment outcomes used in 
the study were as per WHO definitions for 
tuberculosis (11) as follows: 
 Cured: Initially sputum smear positive patient 
who has completed treatment and had negative 
sputum smears on two occasions, one of which 
is at the end of the treatment is declared as 
cured. 
 Treatment completed:  Initially sputum smear 
negative patient who has received full course of 
treatment and has not become smear positive at 
the end of the treatment;  
Or  
Extra pulmonary TB patient who has received full 
course of treatment and has not become smear 
positive during or at the end of treatment is also 
declared as treatment completed. 
 Treatment Success: The sum of cured and 
treatment completed. 
 Treatment Failed: Any TB patient who is smear 
positive at five months or more after starting the 
treatment is considered as ‘Treatment Failed’. 
 Lost to Follow up: A TB Patient who did not start 
treatment or whose treatment was interrupted 
for 2 consecutive months or more. 
 Died: Patient who died during the course of 
treatment regardless of cause is declared as 
‘Died’. 
Ethical Approval: Ethical approval to conduct the 
study was sought from the ethical committee of 
State Health Society, Chandigarh, vide letter number 
NRHM/Chd/12/205. 
Data Analysis: The data was analyzed using 
Microsoft excel and SPSS software version 21. 
Results 
A total of 3551 patients were registered under 
RNTCP for treatment of tuberculosis during the study 
period. Out of these patients, 37 diagnosed TB 
patients were referred from the ART center at 
PGIMER, Chandigarh for initiation of TB treatment. 
Among the total patients put on DOTS (3,551), 63.2% 
(2,246) were males. 
Majority of TB cases, 1,340 (37%) occurred in the age 
group of 29 - 39 years having maximum number of 
infected males 883 (65.9%) than in any other age 
group. In age group 18 - 28 years, 48.3% females 
were infected as compared to 34.1% in 29 - 39 years 
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age group. Thereafter, it was seen that as the age 
advanced, the number of TB patients decreased 
(Figure 1). 
Although all the TB patients were referred to ICTC for 
counselling and HIV testing, however there were 35 
(0.98%) such TB patients who did not get their HIV 
status tested probably because of the social taboo 
associated with HIV. A total of 3,516 (99.02%) TB 
patients had their blood tested for HIV. Out of these 
patients, 88 (2.47%) were tested positive for HIV 
(Table 1). Among the 88 HIV positive individuals, 37 
patients were referred from ART centre and were 
diagnosed as having tuberculosis at the DMC 
situated at PGIMER, Chandigarh.  All of these 
patients were subsequently initiated on ART and 
DOTS. 
On analyzing the data, HIV positive status was found 
to be significantly associated with occurrence of 
extra pulmonary tuberculosis (χ2= 17.42; df 2; p 
0.0001). Out of 88 TB-HIV co-infected patients, 
57.95% had extra pulmonary type of tuberculosis as 
compared to 36.49% extra pulmonary tuberculosis 
among the HIV negative patients. Majority of the HIV 
negative TB patients (63.51%) were found to have 
pulmonary tuberculosis (63.51%). (Table 2) 
Table 3 shows that among all the HIV positive 
patients, category - I of anti-tubercular treatment 
was seen in 76.14% patients. Category - II treatment 
was found to be slightly more among the HIV positive 
TB patients as compared to the HIV negative 
patients. However, the results were not statistically 
significant showing no association of previous TB 
exposure and reoccurrence of TB infection among 
the HIV positive patients. 
Out of all the TB-HIV co-infected patients, 29.55% 
were declared cured at the end of the treatment. A 
total of 63.64% of co-infected patients had 
completed their treatment as compared to 47.32% 
among the patients infected with tuberculosis only. 
On statistical analysis, the result was found to be 
highly significant with a p value <0.0001. None of the 
co-infected patients defaulted from the treatment 
whereas loss to follow up rate was 2.19% among the 
HIV negative patients and 2.86% among the patients 
with unknown HIV status. Treatment Failure rate was 
seen to be highest among the patient with unknown 
HIV status (11.43%) followed by 4.55% in the HIV-TB 
co-infected patients. From the total sample, 2.19% 
(78) patients were later diagnosed as having Drug 
resistant tuberculosis with only one (01) patient 
being co-infected with HIV. However, switching over 
to category - IV (Drug Resistant Tuberculosis) was 
seen to be significantly associated with positive HIV 
status (γ2: 225; df=2; p value <0.0001). Death as an 
outcome was significantly associated with HIV 
positive status (1.14%) as compared to HIV negative 
patients (0.88%) (Table 4). 
Discussion  
TB is the most common life-threatening 
opportunistic infection in patients with HIV/AIDS in 
developing countries. In this study, it was found out 
that 99% of the patients knew their HIV status. Only 
a fraction of patients did not get their HIV status 
tested at any of the ICTC in the city. This shows an 
effective referral mechanism between RNTCP and 
National AIDS Control Organization (NACO), 
Chandigarh. All the chest symptomatic patients 
coming to the 17 DMCs were appropriately 
categorized and put on ATT by the concerned 
medical officer. Prevalence of co-infection among 
the TB patients was found to be 2.47% as opposed to 
20.5% reported by Oshi et al (12) in Nigeria in 2014. 
No significant association was found among the 
occurrence of co-infection and retreatment cases. 
However, extra-pulmonary TB was found to occur in 
higher frequency among the HIV positive patients, 
similar findings were also reported by Sharma et al 
(13) in northern India. This is in contrast to the 
findings reported by Shastri et al (19) in Karnataka 
where they reported pulmonary involvement in 
about 70% of patients. This could be because of lack 
of reporting or diagnosis of extra pulmonary 
tuberculosis among the HIV positive individuals. TB 
being most common opportunistic infection among 
the HIV positive individuals puts them at a greater 
risk of being advanced immune-suppressant. Better 
and quick diagnostic techniques are required for the 
diagnosis of TB among the HIV positive individuals in 
order to reduce the mortality associated with co-
infection state. 
More than 80% of TB-HIV co-infected patients had 
successfully completed their treatment and were 
cured of tuberculosis. Similar findings were reported 
by Sharma et al (15) in northern India.  
Dedication and commitment of co-infected patients 
and the associated staff members of DMC and ART 
center in getting the TB treatment completed was 
seen as there was absolutely no default of treatment 
reported among the TB-HIV co-infected patients. 
This result was found to be in concordance with the 
findings reported by Shastri et al (14) in Karnataka. 
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Treatment default was found to be higher among the 
TB patients with unknown HIV status, probably due 
to their careless attitude towards their disease. 
Death rate was contrastingly found to be higher 
among the HIV positive patients. Similar results were 
also published by WHO (15) in 2014 showing a case 
fatality rate of about 13% among the TB-HIV co-
infected patients. 
Conclusion 
Co-infected patients showed better TB treatment 
success rates with no default in the treatment. 
Treatment failure rate was more among the co-
infected patients may be owing to their immune-
compromised state. Death rate among the co-
infected patients was considerably higher among the 
TB-HIV co-infected patients. Integration of TB-HIV 
collaborative activities at every level will strengthen 
our battle to control TB and HIV globally. There is an 
urgent need to strengthen our efforts of ACSM 
(Advocacy, Communication and Social Mobilization) 
to motivate the patients for testing of their HIV 
status and hence, to reduce the morbidity and 
mortality associated with co-infection. 
Recommendation 
TB-HIV co-infection epidemic is a public health 
problem which can be zeroed down with effective 
linkage between RNTCP and NACP. Prompt diagnosis 
and treatment of active TB patients will help in 
bringing down the morbidity and mortality 
associated with TB-HIV co-infection. 
Limitation of the study 
Excluding the patients taking anti-tubercular 
treatment from the private sources and not 
registered under RNTCP as only co-infected patients 
taking treatment under RNTCP in Chandigarh have 
been included in the study.  
Another limitation is non-availability of information 
regarding the sites of involvement in the extra 
pulmonary tuberculosis. Treatment completion rates 
depend a lot on the site of extra pulmonary infection. 
Relevance of the study 
The present study provides an estimate for the 
prevalence of TB/HIV co-infection in Chandigarh. The 
study also adds to the current knowledge of 
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Tables 
TABLE 1  PREVALENCE OF HIV INFECTION AMONG TB PATIENTS 
 Frequency Percent 
HIV + 88 2.47 
HIV- 3428 96.53 
Unknown 35 0.98 
Total 3551 100 
 
TABLE 2  ASSOCIATION OF HIV STATUS AND TYPE OF TUBERCULOSIS (N=3516) 
 Type of Tuberculosis   
Pulmonary Extra pulmonary Total 
HIV + 37 (42.05%) 51 (57.95%) 88 (100%) 
HIV - 2177 (63.51%) 1251 (36.49%) 3428 (100%) 
Total 2214 1302 3516 
γ2= 17.42; df 2; p 0.0001 *A total of 35 patients with unknown HIV status have been excluded from the analysis 
 
TABLE 3  CATEGORY OF TREATMENT AMONG TUBERCULOSIS PATIENTS 
HIV Status Treatment category Total 
Category I Category II 
HIV + 67 (76.14%) 21 (23.86%) 88 
HIV - 2688 (78.41%) 740 (21.59%) 3428 
Unknown 26 (74.29%) 9 (25.71%) 35 
Total 2781 (78.32%) 770 (21.68%) 3551 
 
TABLE 4  TREATMENT OUTCOME AMONG HIV POSITIVE AND HIV NEGATIVE TB PATIENTS (N=3,551) 
Outcome HIV Positive HIV negative Unknown γ 2 p value 
Cured 26(29.55%) 1522(44.40%) 15(42.86%) 0.432E+04; df 2 <0.0001 
Treatment complete 56(63.64%) 1622(47.32%) 14(40%) 0.448E+04; df2 <0.0001 
Loss to Follow up 0 75(2.19%) 4(11.43%) 219; df2 <0.0001 
Treatment Failure 4(4.55%) 102(2.98%) 2 (4.86%) 266; df2 <0.0001 
Treatment regimen changed to cat IV 1(1.14%) 77(2.25%) 0 225; df2 <0.0001 
Died 1(1.14%) 30(0.88%) 1(2.86%) 78.8; df2 <0.0001 
Total 88(2.47%) 3428(96.54%) 35(0.99%) - - 
 
Figures 
FIGURE 1 AGE AND SEX WISE DISTRIBUTION OF TB PATIENTS 
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